3rd RSC Anglo-Nordic Medicinal Chemistry Symposium

3rd RSC Anglo-Nordic Medicinal Chemistry Symposium

Tuesday-Friday, 13th-16th June 2023

Hotel Comwell Borupgaard, Snekkersten, Denmark

Downloads and Links
First announcement
Second Announcement
Bursary application form – closing date is 3rd May 2023
Venue website (showing location)
Danish travel information website
Twitter hashtag – #ANMC2023

This 2.5 day symposium is the third in the very successful series of biannual meetings started in 2017 containing high quality international speakers from industry and academia on topics of Medicinal Chemistry and related enabling technologies. Organised by the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry, together with Nordic affiliates, the meeting promises to be an exciting and invigorating gathering packed with fantastic opportunities to disseminate knowledge and expand networks.

The event will include first rate lectures, poster session, trade exhibition, ample networking opportunities, welcome buffet on Tuesday, exceptional location, venue and accommodation.

Who should attend?
Medicinal chemists at all career stages. Scientists with an interest in drug discovery or new technologies that can be applied to the drug discovery process.

Call for Papers
Abstract submission is open now. Please click here to submit your abstract. Papers are invited for both short talks and posters. The closing dates are 31st January 2023 (oral) and 24th March 2023 (poster). Some posters will be selected for flash oral presentation.

Programme Themes
The scientific programme will feature themed lectures, focusing on medicinal chemistry and related new enabling technologies and disciplines across a range of drug targets and modalities. A distinguishing feature of this symposium is the collegiate style with the delegates living at the premises which encourages an atmosphere of information sharing and learning.

Confirmed Speakers
Chemical probes in target discovery
Paul Brennan, Structural Genomics Consortium, UK

Humanizing Drug Discovery
Mark Bunnage, SVP Vertex, US

Developing chemical tools to study epigenetic proteins and processes
Stuart Conway, University of Oxford, UK

Structural determinants of orally bioavailable Ro5 and bRo5 drugs
Nichola Davies, AstraZeneca

Title TBC
Ray Deshaies, SVP Amgen, US

The Discovery and Development of Novel Small Molecule IL17A Inhibitors
Anne Foley, UCB, UK

Discovery of inhaled sGC Activator Mosliciguat (BAY 1237592) for the Treatment of Pulmonary Hypertension
Michael Hahn, Bayer, DE

Cryo-EM and X-ray structure-based methods in membrane protein drug discovery
Michael Hennig, leadXpro, CH

Discovery of the selective and orally bioavailable VHL-recruiting PROTAC ACBI2 showing SMARCA2 degradation in vivo
Christiane Kofink, Boehringer Ingelheim, DE

Discovery of an oral, rule of 5 compliant, il-17a protein-protein interaction modulator for the treatment of psoriasis and other inflammatory diseases
Maja Lambert, LEO, DE

Application of the cellular thermal shift assay in drug discovery
Thomas Lundbäck, AstraZeneca, SE

Heterocyclic compounds as delta-5 desaturase inhibitors
Ana Minatti
, Amgen, USA

PAC-FragmentDEL: PhotoActivated Covalent capture of DNA-Encoded Fragments to identify ligands for challenging targets
James Murray, Vernalis, UK

Molecular Glues to Stabilize 14-3-3 Protein-Protein Interactions
Christian Ottmann, Eindhoven University of Technology, NL

AI applied to drug design
Quentin Perron, IKTOS, FR

From Serendipity to Rational Design: Taking Molecular Glue Degraders to New Heights
Andreas Ritzen, Monte Rosa Therapeutics, CH

Discovery of conformationally restricted macrocyclic MCL-1 PPI inhibitors for the treatment of hematological diseases
Ingrid Velter, Janssen Research  Development, BE

The Identification of a GPR52 Agonist clinical candidate; a potential therapy for schizophrenia and related psychiatric disorders (first disclosure)
Steve Watson, Sosei Heptares

Optimisation of Mer/Axl kinase inhibitors for immuno-oncology
Jon Winter-Holt, AstraZeneca, UK

The previous meetings were very popular and fully subscribed to the maximum capacity of 140 attendees.

Registration is now open, click here to register
Early bird registration deadline is 24th March, 2023 23:59(GMT)
Registration deadline: 5th June, 2023, 17:00 (GMT)

Registration Fees

Early bird rate

RSC Member £580.00
Non-Member £665.00
RSC Student** Member* £440.00
Student** Non-member (undergraduate and post-graduate) £485.00

Late registration rate

RSC Member £635.00
Non-Member £720.00
RSC Student** Member* £495.00
Student** Non-member (undergraduate and post-graduate) £540.00

* Member is a paid-up member of the RSC
** Student rates apply to undergraduate and post-graduate students only, but not post-doctoral students.

Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.

Student Bursaries
A limited number of student bursaries are available for this meeting (funded by the RSC-BMCS). The closing date for applications is 3rd May 2023. Please download this bursary application form.

Exhibitor Opportunities
The exhibition package will include for one full delegate with access to the technical programme.

Each exhibitor stand will comprise a space measuring 1.5 metres wide with electricity and a table measuring 1.5 m wide x 0.75 m deep x 0.72 m high.

Delegate pack inserts may be booked once registration has opened, comprising no more than two pages of A4 fixed together.

Sponsorship Opportunities
We are grateful to our confirmed sponsors, AstraZeneca, LEO Pharma, H Lundbeck, Enamine and Domainex for their valued support.


We are grateful to our supporter: EFMC

Address: Hotel Comwell Borupgaard, Nørrevej 80, Snekkersten 3070, Denmark
Venue website (showing location)

These are guide prices which you should verify for yourself, please.
By train: 55 minutes from Copenhagen airport/railway station to Snekkersten. Cost £10-£17
By taxi: 45 minutes from Copenhagen airport/railway station to Snekkersten. Cost £95-£100
By bus and train: 1h 50m from Copenhagen airport/railway station to Snekkersten. Cost £7-£20

Danish travel information website
This is a map with travel modes and charges from Copenhagen station.

Accommodation and Dinners Package
The Accommodation and Dinners Package will comprise:
– three nights’ bed and breakfast accommodation at the conference Hotel Comwell Borupgaard (from Tuesday to Thursday inclusive)
– three-course dinner with drinks on Wednesday
– conference dinner with drinks on Thursday
It will be advisable to book this at the time of registration.

Organising Committee
Sharan Bagal (chair), AstraZeneca, UK
Kevin N Dack, LEO Pharma, DK
Adrian Hall (treasurer), UCB, BE
Malin Lemurell, AstraZeneca, SE
Anette Graven Sams, Lundbeck, DK
Morten Jørgensen (posters), LEO Pharma, DK

Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333